What one share of Monopar Therapeutics holds
Monopar Therapeutics Inc. (“Monopar,” the “Company,” “we,” “us,” and “our” and similar terms mean Monopar Therapeutics Inc. and its subsidiaries except where the context otherwise requires) is a clinical-stage biopharmaceutical company developing an innovative treatment for Wilson disease and novel radiopharmaceuticals for oncology.
Monopar Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$2.18 |
|---|---|
| Cash and investments | $7.86 |
| Book value | $19.50 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.00 | −$9.43 | — | — | — | $5.18 |
| 2018 | $0.00 | −$1.74 | — | — | — | $3.72 |
| 2019 | $0.00 | −$2.27 | — | — | — | $5.96 |
| 2020 | — | −$2.88 | — | — | — | $6.85 |
| 2021 | — | −$3.65 | — | — | — | $7.52 |
| 2022 | — | −$4.13 | — | — | — | $3.90 |
| 2023 | — | −$3.04 | — | — | — | $1.87 |
| 2024 | $0.00 | −$4.11 | — | — | — | $9.02 |
| 2025 | $0.00 | −$1.85 | — | — | — | $20.60 |
Common questions about Monopar Therapeutics
How much does one share of Monopar Therapeutics earn?
Over the last 12 months, Monopar Therapeutics lost $2.18 for each share.
Does Monopar Therapeutics pay a dividend?
Monopar Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Monopar Therapeutics’s book value per share?
Monopar Therapeutics’s book value is $19.50 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Monopar Therapeutics have?
Each share of Monopar Therapeutics has $7.86 of cash and investments, as of June 30, 2026.
Has Monopar Therapeutics bought back shares?
Monopar Therapeutics’s share count rose about 322% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.